In the latest constitutional challenge against the Consumer Financial Protection Bureau, the agency was accused Monday of overstepping its authority by attempting to regulate the practice of law and collect personal financial data.

The truly fascinating discovery controversy developing in the Federal Trade Commission's antitrust case against Cephalon, proves, once again, that litigation sometimes makes for very strange bedfellows.

After Shirley Boles's first trial against Merck ended in a mistrial, her lawyer, Tim O'Brien of Levin Papantonio, talked to the jury about where he'd gone wrong. He's apparently a good listener: The second time around, he and his co-counsel handed Merck its first Fosamax defeat.

The hedge fund, which helped finance the $5.4 billion acquisition of the Manhattan properties in 2006, doesn't like the proposed foreclosure plan--and its Gibbs & Bruns lawyers say the company leading the action has a conflict of interest.